Global (United States, European Union and China) Oncology Injection Drug Market Research Report 2019-2025

Table of Contents

1 Oncology Injection Drug Market Overview

• 1.1 Product Overview and Scope of Oncology Injection Drug
• 1.2 Oncology Injection Drug Segment by Type
  • 1.2.1 Global Oncology Injection Drug Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Organs
  • 1.2.3 Central Nervous System
  • 1.2.4 Circulatory/Musculoskeletal System
• 1.3 Oncology Injection Drug Segment by Application
  • 1.3.1 Oncology Injection Drug Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Lymphoma
  • 1.3.3 Myeloma
  • 1.3.4 Prostate Cancer
• 1.4 Global Oncology Injection Drug Market Size Estimates and Forecasts
  • 1.4.1 Global Oncology Injection Drug Revenue 2015-2026
  • 1.4.2 Global Oncology Injection Drug Sales 2015-2026
  • 1.4.3 Oncology Injection Drug Market Size by Region: 2020 Versus 2026

2 Global Oncology Injection Drug Market Competition by Manufacturers

• 2.1 Global Oncology Injection Drug Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Oncology Injection Drug Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Oncology Injection Drug Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Oncology Injection Drug Manufacturing Sites, Area Served, Product Type
• 2.5 Oncology Injection Drug Market Competitive Situation and Trends
  • 2.5.1 Oncology Injection Drug Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Oncology Injection Drug Players (Opinion Leaders)

3 Oncology Injection Drug Retrospective Market Scenario by Region

• 3.1 Global Oncology Injection Drug Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Oncology Injection Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Oncology Injection Drug Market Facts & Figures by Country
  • 3.3.1 North America Oncology Injection Drug Sales by Country
  • 3.3.2 North America Oncology Injection Drug Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Oncology Injection Drug Market Facts & Figures by Country
  • 3.4.1 Europe Oncology Injection Drug Sales by Country
  • 3.4.2 Europe Oncology Injection Drug Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Oncology Injection Drug Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Oncology Injection Drug Sales by Region
  • 3.5.2 Asia Pacific Oncology Injection Drug Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Oncology Injection Drug Market Facts & Figures by Country
  • 3.6.1 Latin America Oncology Injection Drug Sales by Country
  • 3.6.2 Latin America Oncology Injection Drug Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Oncology Injection Drug Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Oncology Injection Drug Sales by Country
  • 3.7.2 Middle East and Africa Oncology Injection Drug Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Oncology Injection Drug Historic Market Analysis by Type

• 4.1 Global Oncology Injection Drug Sales Market Share by Type (2015-2020)
• 4.2 Global Oncology Injection Drug Revenue Market Share by Type (2015-2020)
• 4.3 Global Oncology Injection Drug Price Market Share by Type (2015-2020)
• 4.4 Global Oncology Injection Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Oncology Injection Drug Historic Market Analysis by Application

• 5.1 Global Oncology Injection Drug Sales Market Share by Application (2015-2020)
• 5.2 Global Oncology Injection Drug Revenue Market Share by Application (2015-2020)
• 5.3 Global Oncology Injection Drug Price by Application (2015-2020)

6 Company Profiles and Key Figures in Oncology Injection Drug Business

• 6.1 Taj Oncology
  • 6.1.1 Corporation Information
  • 6.1.2 Taj Oncology Description, Business Overview and Total Revenue
  • 6.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Taj Oncology Products Offered
  • 6.1.5 Taj Oncology Recent Development
• 6.2 S.G. Biopharm
  • 6.2.1 S.G. Biopharm Oncology Injection Drug Production Sites and Area Served
  • 6.2.2 S.G. Biopharm Description, Business Overview and Total Revenue
  • 6.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 S.G. Biopharm Products Offered
  • 6.2.5 S.G. Biopharm Recent Development
• 6.3 AdvaCare
  • 6.3.1 AdvaCare Oncology Injection Drug Production Sites and Area Served
  • 6.3.2 AdvaCare Description, Business Overview and Total Revenue
  • 6.3.3 AdvaCare Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 AdvaCare Products Offered
  • 6.3.5 AdvaCare Recent Development
• 6.4 Merrimack
  • 6.4.1 Merrimack Oncology Injection Drug Production Sites and Area Served
  • 6.4.2 Merrimack Description, Business Overview and Total Revenue
  • 6.4.3 Merrimack Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Merrimack Products Offered
  • 6.4.5 Merrimack Recent Development
• 6.5 Celgene
  • 6.5.1 Celgene Oncology Injection Drug Production Sites and Area Served
  • 6.5.2 Celgene Description, Business Overview and Total Revenue
  • 6.5.3 Celgene Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Celgene Products Offered
  • 6.5.5 Celgene Recent Development
• 6.6 Allos Therapeutics
  • 6.6.1 Allos Therapeutics Oncology Injection Drug Production Sites and Area Served
  • 6.6.2 Allos Therapeutics Description, Business Overview and Total Revenue
  • 6.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Allos Therapeutics Products Offered
  • 6.6.5 Allos Therapeutics Recent Development
• 6.7 Ferring Pharmaceuticals
  • 6.6.1 Ferring Pharmaceuticals Oncology Injection Drug Production Sites and Area Served
  • 6.6.2 Ferring Pharmaceuticals Description, Business Overview and Total Revenue
  • 6.6.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Ferring Pharmaceuticals Products Offered
  • 6.7.5 Ferring Pharmaceuticals Recent Development
• 6.8 Genzyme
  • 6.8.1 Genzyme Oncology Injection Drug Production Sites and Area Served
  • 6.8.2 Genzyme Description, Business Overview and Total Revenue
  • 6.8.3 Genzyme Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Genzyme Products Offered
  • 6.8.5 Genzyme Recent Development
• 6.9 Eli Lilly
  • 6.9.1 Eli Lilly Oncology Injection Drug Production Sites and Area Served
  • 6.9.2 Eli Lilly Description, Business Overview and Total Revenue
  • 6.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Eli Lilly Products Offered
  • 6.9.5 Eli Lilly Recent Development
• 6.10 Praecis Pharmaceuticals
  • 6.10.1 Praecis Pharmaceuticals Oncology Injection Drug Production Sites and Area Served
  • 6.10.2 Praecis Pharmaceuticals Description, Business Overview and Total Revenue
  • 6.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 Praecis Pharmaceuticals Products Offered
  • 6.10.5 Praecis Pharmaceuticals Recent Development
• 6.11 Millennium Pharmaceuticals
  • 6.11.1 Millennium Pharmaceuticals Oncology Injection Drug Production Sites and Area Served
  • 6.11.2 Millennium Pharmaceuticals Oncology Injection Drug Description, Business Overview and Total Revenue
  • 6.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 Millennium Pharmaceuticals Products Offered
  • 6.11.5 Millennium Pharmaceuticals Recent Development
• 6.12 Debiopharm
  • 6.12.1 Debiopharm Oncology Injection Drug Production Sites and Area Served
  • 6.12.2 Debiopharm Oncology Injection Drug Description, Business Overview and Total Revenue
  • 6.12.3 Debiopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.12.4 Debiopharm Products Offered
  • 6.12.5 Debiopharm Recent Development
• 6.13 Alza
  • 6.13.1 Alza Oncology Injection Drug Production Sites and Area Served
  • 6.13.2 Alza Oncology Injection Drug Description, Business Overview and Total Revenue
  • 6.13.3 Alza Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.13.4 Alza Products Offered
  • 6.13.5 Alza Recent Development
• 6.14 CordenPharma
  • 6.14.1 CordenPharma Oncology Injection Drug Production Sites and Area Served
  • 6.14.2 CordenPharma Oncology Injection Drug Description, Business Overview and Total Revenue
  • 6.14.3 CordenPharma Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.14.4 CordenPharma Products Offered
  • 6.14.5 CordenPharma Recent Development
• 6.15 Pharmascience
  • 6.15.1 Pharmascience Oncology Injection Drug Production Sites and Area Served
  • 6.15.2 Pharmascience Oncology Injection Drug Description, Business Overview and Total Revenue
  • 6.15.3 Pharmascience Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
  • 6.15.4 Pharmascience Products Offered
  • 6.15.5 Pharmascience Recent Development

7 Oncology Injection Drug Manufacturing Cost Analysis

• 7.1 Oncology Injection Drug Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Oncology Injection Drug
• 7.4 Oncology Injection Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Oncology Injection Drug Distributors List
• 8.3 Oncology Injection Drug Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Oncology Injection Drug Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Oncology Injection Drug by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Oncology Injection Drug by Type (2021-2026)
• 10.2 Oncology Injection Drug Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Oncology Injection Drug by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Oncology Injection Drug by Application (2021-2026)
• 10.3 Oncology Injection Drug Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Oncology Injection Drug by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Oncology Injection Drug by Region (2021-2026)
• 10.4 North America Oncology Injection Drug Estimates and Projections (2021-2026)
• 10.5 Europe Oncology Injection Drug Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Oncology Injection Drug Estimates and Projections (2021-2026)
• 10.7 Latin America Oncology Injection Drug Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Oncology Injection Drug Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List